Skip to main content
Psychiatric Annals, 2013;24(3):137–141
Cite this articlePublished Online:https://doi.org/10.3928/0048-5713-19940301-09Cited by:14

Abstract

By the early 1960s the 5-HT hypothesis of the action of LSD had become firmly established in the field.

  • 1. Shaw E, Woolley DW. Some serotonin-like activities of lysergic acid diethylamide. Science. 1956; 124:121-123.

    > Google Scholar
  • 2. Freedman DX. Effects of LSD-25 on brain serotonin. J Pharmacol Exp Ther. 1961; 134:160-166.

    > Google Scholar
  • 3. Dahlstr'om A, Fuxe K. Evidence for the existence of monoamine-containing neurons in the central nervous system, 1: demonstration of monoamines in the cell bodies of brain stem neurons. Acta Physiol Scand. 1965; 62(suppl); 232:1-55.

    > Google Scholar
  • 4. Aghajanian GK, Foote WE. Sheard MH. Lysergic acid diethylamide: sensitive neuronal units in the midbrain raphe. Science. 1968; 161:706-708.

    > Google Scholar
  • 5. Aghajanian GK, Haigler HJ, Bloom FE. Lysergic acid diethylamide and serotonin: direct actions on serotonincontaining neurons. Life Sci. 1972; 1:615-622.

    > Google Scholar
  • 6. Aghajanian GK, Haigler HJ. Hallucinogenic indoleamines: preferential action upon presynaptic receptors. Psychopharm Comm. 1975; 1:619-629.

    > Google Scholar
  • 7. Haigler HJ, Aghajanian GK. Mescaline and LSD: direct and indirect effects on serotonin-containing neurons in brain. Eur J Pharmacol. 1973; 21:53-60.

    > Google Scholar
  • 8. Schmidt AW, Peroutka SJ. 5-Hydroxytryptamine receptor "families." Neuropsychopharmacology . 1989; 3:2242-2249.

    > Google Scholar
  • 9, Glennon RA, Titeler M, McKennay JD. Evidence for 5-HT^sub 2^ involvement in the mechanism of action of hallucinogenic agents. Life Sci. 1984; 35:2505-2511.

    > Google Scholar
  • 10. Titeler M, Lyon RA, Glennon RA. Radioligand binding evidence implicates the brain 5-HT^sub 2^ receptor as a site of action for LSD and phenylisopropylamine hallucinogens. Psychopharmacology. 1988; 94:213-216.

    > Google Scholar
  • 11. Pazos A, Cortes R, Palacios JM. Quantitative autoradiographic mapping of serotonin receptors in the rat brain, I: serotonin-2 receptors. Brain Res. 1985; 346:231-249.

    > Google Scholar
  • 12. Mengod G, Pompeiano M, Martinez-Mir MI. Palacios JM. Localization of the mRNA for the 5-HT^sub 2^ receptor by in situ hybridization histochemistry; correlation with the distribution of receptor sites. Brain Res. 1990; 524:139-143.

    > Google Scholar
  • 13. Morilak DA Garlow SJ, Ciaranello RD. Immunocytochemical localization and description of neurons expressing serotonin2 receptors in the rat brain. Neuroscience. 1993; 4:701-717.

    > Google Scholar
  • 14. Cedarbaum JM, Aghajanian GK Activation of locus coeruleus neurons by peripheral stimuli: modulation by a collateral inhibitory mechanism. Life Sci. 1978; 23:1383-1391.

    > Google Scholar
  • 15. Foote SL, Aston-Jones G, Bloom FE. Impulse activity of locus coeruleus neurons in awake rats and monkeys is a function of sensory stimulation and arousal. Proc Natl. Acad Sci. 1980;77:3033-3037.

    > Google Scholar
  • 16. Aghajanian GK. Mescaline and LSD facilitate the activation of locus coeruleus neurons by peripheral stimuli. Brain Res. 1980; 186:492-498.

    > Google Scholar
  • 17. Rasmussen K, Aghajanian GK Effects of hallucinogens on spontaneous and sensory-evoked locus coeruleus unit activity in the rat: reversal by selective 5-HT^sub 2^ antagonists. Brain Res. 1986; 385:395-400.

    > Google Scholar
  • 18. Rasmussen K, Aghajanian GK Potency of antipsychotics in reversing the effects of a hallucinogenic drug on locus coeruleus neurons correlates with 5-HT^sub 2^ binding affinity. Neuropsychopharmacology. 1988; 1:101-107.

    > Google Scholar
  • 19. Araneda R, Andrade R. 5-Hydroxytryptamine2 and 5-hydroxytryptamine1A receptors mediate opposing responses on membrane excitability in rat association cortex. Neuroscience. 1991; 40:399-412.

    > Google Scholar
  • 20. Davies MF, Deisz RA, Prince DA, Peroutka SJ. Two distinct effects of 5-hydroxytryptamine on single cortical neurons. Brain Res. 1987; 423:347-352.

    > Google Scholar
  • 21. Sheldon PW, Aghajanian GK. Serotonin (5-HT) induces IPSPs in pyramidal layer of rat piriform cortex: evidence for the involvement of a 5-HT^sub 2^-activated interneuron. Brain Res. 1990; 506:62-69.

    > Google Scholar
  • 22. Gellman RL, Aghajanian GK 5-HT^sub 2^-receptor mediated excitation of interneurons in piriform cortex: antagonism by atypical antipsychotic drugs. Neuroscience. 1994; 58:515-525.

    > Google Scholar
  • 23. Colpaert FC, Niemegeers JE, Janssen PAJ. A drug discrimination analysis of lysergic acid diethylamide (LSD): in vivo agonist and antagonist effects of purported 5-hydroxvtryptamine antagonists and of pirenperone, a LSD antagonist. J Pharmacol Exp Ther. 1982; 82:206-214.

    > Google Scholar
  • 24. Heym J, Rasmussen K, Jacobs BL. Some behavioral effects of hallucinogens are mediated by a postsynaptic serotonergic action: evidence from single unit studies in freely moving cats. Eur J Pharmacol. 1984; 101:57-68.

    > Google Scholar
  • 25. Lucki I1 Nobler NS, Frazer A. Differential actions of serotonin antagonists on two behavioral models of serotonin receptor activation in the rat. J Pharmacol Exp Ther. 1984; 228:133-138.

    > Google Scholar
  • 26. Haigler HJ, Aghajanian GK Lysergic acid diethylamide and serotonin: a comparison of effects on serotonergic neurone and neurons receiving a serotonergic input. J Pharmacol Exp Ther. 1974; 188:688-699.

    > Google Scholar
  • 27. Arora RC, Meltzer HY. Serotonin2 (5-HT^sub 2^) receptor binding in the frontal cortex of schizophrenic patients. J Neural Trans. 1991; 85:19-29.

    > Google Scholar
  • 28. Benes FV, McSparen J, Bird ED, SanGiovanni JP, Vincent SL. Deficits in small interneurons in prefrontal and cingulate cortices of schizophrenic and schizoaffective patients. Arch Gen Psychiatry. 1991; 48:996-1001.

    > Google Scholar

We use cookies on this site to enhance your user experience. For a complete overview of all the cookies used, please see our privacy policy.

×